On the public citation graph
Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells
0 signed · 289 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/humu.21277openalex-snapshot
Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update
inferredcites →https://doi.org/10.1002/mds.22798openalex-snapshot
The role of parkin in familial and sporadic Parkinson's disease
inferredcites →https://doi.org/10.1007/978-1-60761-369-5_19openalex-snapshot
Differentiation of Neural Precursors and Dopaminergic Neurons from Human Embryonic Stem Cells
inferredcites →https://doi.org/10.1016/j.cell.2007.11.019openalex-snapshot
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
inferredcites →https://doi.org/10.1016/j.expneurol.2009.12.021openalex-snapshot
In vivo assessment of brain monoamine systems in parkin gene carriers: A PET study
inferredcites →https://doi.org/10.1016/j.neuron.2010.04.034openalex-snapshot
Genetic Animal Models of Parkinson's Disease
inferredcites →https://doi.org/10.1016/j.neuron.2010.10.014openalex-snapshot
Genetic Analysis of Pathways to Parkinson Disease
inferredcites →https://doi.org/10.1016/j.stem.2008.08.003openalex-snapshot
A High-Efficiency System for the Generation and Study of Human Induced Pluripotent Stem Cells
inferredcites →https://doi.org/10.1016/s0026-895x(25)08925-4openalex-snapshot
Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter.
inferredcites →https://doi.org/10.1038/33416openalex-snapshot
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
inferredcites →https://doi.org/10.1038/383332a0openalex-snapshot
Engrailed-1 as a target of the Wnt-1 signalling pathway in vertebrate midbrain development
inferredcites →https://doi.org/10.1038/77060openalex-snapshot
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
inferredcites →https://doi.org/10.1038/mp.2010.50openalex-snapshot
Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory
inferredcites →https://doi.org/10.1038/nbt.1529openalex-snapshot
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
inferredcites →https://doi.org/10.1038/nbt.1783openalex-snapshot
A functionally characterized test set of human induced pluripotent stem cells
inferredcites →https://doi.org/10.1038/ncb1441openalex-snapshot
A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K–Akt signalling
inferredcites →https://doi.org/10.1038/ncb1981openalex-snapshot
Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease
inferredcites →https://doi.org/10.1056/nejmoa0809335openalex-snapshot
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
inferredcites →https://doi.org/10.1073/pnas.0401420101openalex-snapshot
Regulation of PPARγ coactivator 1α (PGC-1α) signaling by an estrogen-related receptor α (ERRα) ligand
inferredcites →https://doi.org/10.1073/pnas.0409598102openalex-snapshot
Parkin-deficient mice are not a robust model of parkinsonism
inferredcites →https://doi.org/10.1073/pnas.0910012107openalex-snapshot
Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency
inferredcites →https://doi.org/10.1074/jbc.271.34.20885openalex-snapshot
The Dopamine Transporter Carboxyl-terminal Tail
inferredcites →https://doi.org/10.1074/jbc.m201926200openalex-snapshot
Oligomerization and Trafficking of the Human Dopamine Transporter
inferredcites →https://doi.org/10.1074/jbc.m409282200openalex-snapshot
Parkin Increases Dopamine Uptake by Enhancing the Cell Surface Expression of Dopamine Transporter
inferredcites →https://doi.org/10.1074/jbc.m510926200openalex-snapshot
Parkin Suppresses the Expression of Monoamine Oxidases
inferredcites →https://doi.org/10.1083/jcb.200809125openalex-snapshot
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
inferredcites →https://doi.org/10.1093/hmg/ddh180openalex-snapshot
Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis
inferredcites →https://doi.org/10.1093/hmg/ddq550openalex-snapshot
Parkin degrades estrogen-related receptors to limit the expression of monoamine oxidases
inferredcites →https://doi.org/10.1126/science.1151526openalex-snapshot
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
inferredcites →https://doi.org/10.1146/annurev.neuro.22.1.197openalex-snapshot
MONOAMINE OXIDASE: From Genes to Behavior
inferredcites →https://doi.org/10.1172/jci45794openalex-snapshot
Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease
inferredcites →https://doi.org/10.1186/1742-4682-6-21openalex-snapshot
Homeostatic mechanisms in dopamine synthesis and release: a mathematical model
inferredcites →https://doi.org/10.1212/wnl.47.6_suppl_3.161sopenalex-snapshot
Oxidative stress and the pathogenesis of Parkinson's disease
inferredcites →https://doi.org/10.1242/jcs.004127openalex-snapshot
Regulated Nodal signaling promotes differentiation of the definitive endoderm and mesoderm from ES cells
inferredcites →https://doi.org/10.1523/jneurosci.0181-09.2009openalex-snapshot
Mobilization of Calcium from Intracellular Stores Facilitates Somatodendritic Dopamine Release
inferredcites →https://doi.org/10.1523/jneurosci.21-19-07841.2001openalex-snapshot
Novel Ca2+Dependence and Time Course of Somatodendritic Dopamine Release: Substantia Nigra versus Striatum
inferredcites →https://doi.org/10.1634/stemcells.2004-0365openalex-snapshot
Directed Differentiation of Dopaminergic Neuronal Subtypes from Human Embryonic Stem Cells
inferredcites →https://doi.org/10.2967/jnumed.109.063529openalex-snapshot
A Multitracer Dopaminergic PET Study of Young-Onset Parkinsonian Patients With and Without Parkin Gene Mutations
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4818803openalex-extracted
Roles of Ipsc in Advancing Treatments for Neurological Disorders
inferred← citeshttps://doi.org/10.1002/9781119283249.ch7openalex-snapshot
Modeling Genetic and Environment Interactions Relevant to Huntington's and Parkinson's Disease in Human Induced Pluripotent Stem Cells (hiPSCs)‐Derived Neurons
inferred← citeshttps://doi.org/10.1002/adma.201705684openalex-snapshot
Materials for Neural Differentiation, Trans‐Differentiation, and Modeling of Neurological Disease
inferred← citeshttps://doi.org/10.1002/ajmg.b.32918openalex-snapshot
ADHD‐associated PARK2 copy number variants: A pilot study on gene expression and effects of supplementary deprivation in patient‐derived cell lines
inferred← citeshttps://doi.org/10.1002/ana.23596openalex-snapshot
Accelerating progress in induced pluripotent stem cell research for neurological diseases
inferred← citeshttps://doi.org/10.1002/ange.201600224openalex-snapshot
Guided Self‐Propelled Leaping of Droplets on a Micro‐Anisotropic Superhydrophobic Surface
inferred← citeshttps://doi.org/10.1002/anie.201600224openalex-snapshot
Guided Self‐Propelled Leaping of Droplets on a Micro‐Anisotropic Superhydrophobic Surface
inferred← citeshttps://doi.org/10.1002/apxr.202300125openalex-snapshot
1D Photonic Topological Insulators Composed of Split Ring Resonators: A Mini Review
inferred← citeshttps://doi.org/10.1002/cphy.c180025openalex-snapshot
Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models
inferred← citeshttps://doi.org/10.1002/iub.2595openalex-snapshot
Central nervous system organoids for modeling neurodegenerative diseases
inferred← citeshttps://doi.org/10.1002/j.2040-4603.2019.tb00076.xopenalex-snapshot
Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models
inferred← citeshttps://doi.org/10.1002/jcb.24251openalex-snapshot
Dopaminergic differentiation using pluripotent stem cells
inferred← citeshttps://doi.org/10.1002/mds.26113openalex-snapshot
Stem cell reprogramming: Basic implications and future perspective for movement disorders
inferred← citeshttps://doi.org/10.1002/mds.28786openalex-snapshot
Molecular Features of Parkinson's Disease in Patient‐Derived Midbrain Dopaminergic Neurons
inferred← citeshttps://doi.org/10.1002/mds.29434openalex-snapshot
Parkin Maintains Robust Pacemaking in Human Induced Pluripotent Stem Cell‐Derived A9 Dopaminergic Neurons
inferred← citeshttps://doi.org/10.1002/mds.29890openalex-snapshot
Diverse Functions of Parkin in Midbrain Dopaminergic Neurons
inferred← citeshttps://doi.org/10.1002/stem.1854openalex-snapshot
Parkin Mutations Reduce the Complexity of Neuronal Processes in iPSC-Derived Human Neurons
inferred← citeshttps://doi.org/10.1002/stem.3163openalex-snapshot
Generation of homogeneous midbrain organoids with in vivo-like cellular composition facilitates neurotoxin-based Parkinson's disease modeling
inferred← citeshttps://doi.org/10.1007/164_2023_657openalex-snapshot
iPSCs-Derived Neurons and Brain Organoids from Patients
inferred← citeshttps://doi.org/10.1007/5584_2021_643openalex-snapshot
Pluripotent Stem Cell Derived Neurons as In Vitro Models for Studying Autosomal Recessive Parkinson’s Disease (ARPD): PLA2G6 and Other Gene Loci
inferred← citeshttps://doi.org/10.1007/978-1-4614-8066-2_15openalex-snapshot
Disease Modeling and Drug Discovery Using Human Pluripotent Stem Cells
inferred← citeshttps://doi.org/10.1007/978-3-030-55359-3_1openalex-snapshot
Introduction and Basic Concepts in Stem Cell Research and Therapy: The Facts and the Hype
inferred← citeshttps://doi.org/10.1007/978-3-031-07793-7_10openalex-snapshot
Models of Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/978-3-031-94101-6_3openalex-snapshot
Genome Editing and Human-Induced Pluripotent Stem Cells Facilitate Parkinson’s Disease Modeling
inferred← citeshttps://doi.org/10.1007/978-3-319-33486-8_15openalex-snapshot
Simultaneous Activation of Nrf2 and Elevation of Dietary and Endogenous Antioxidants for Prevention and Improved Management of Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-44022-4_15openalex-snapshot
Stem Cells and Neurogenesis for Brain Development, Degeneration and Therapy
inferred← citeshttps://doi.org/10.1007/978-3-319-53889-1_23openalex-snapshot
Stem Cell Technology for (Epi)genetic Brain Disorders
inferred← citeshttps://doi.org/10.1007/978-3-319-59165-0_2openalex-snapshot
Induced Pluripotent Stem Cell Therapy and Safety Concerns in Age-Related Chronic Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/s00018-014-1774-1openalex-snapshot
Neural stem cells in Parkinson’s disease: a role for neurogenesis defects in onset and progression
inferred← citeshttps://doi.org/10.1007/s00401-013-1222-6openalex-snapshot
Human stem cell models of neurodegeneration: a novel approach to study mechanisms of disease development
inferred← citeshttps://doi.org/10.1007/s00401-021-02285-4openalex-snapshot
Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites
inferred← citeshttps://doi.org/10.1007/s00441-017-2749-yopenalex-snapshot
iPS cells in the study of PD molecular pathogenesis
inferred← citeshttps://doi.org/10.1007/s00702-021-02431-yopenalex-snapshot
Protein clearance strategies for disease intervention
inferred← citeshttps://doi.org/10.1007/s00702-023-02730-6openalex-snapshot
Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s00702-024-02866-zopenalex-snapshot
Type A monoamine oxidase; its unique role in mood, behavior and neurodegeneration
inferred← citeshttps://doi.org/10.1007/s10072-014-1989-9openalex-snapshot
Neurodegenerative diseases in a dish: the promise of iPSC technology in disease modeling and therapeutic discovery
inferred← citeshttps://doi.org/10.1007/s10286-019-00614-yopenalex-snapshot
Induced pluripotent stem cells in multiple system atrophy: recent developments and scientific challenges
inferred← citeshttps://doi.org/10.1007/s10545-018-0225-9openalex-snapshot
Induced pluripotent stem cells (iPSCs) as model to study inherited defects of neurotransmission in inborn errors of metabolism
inferred← citeshttps://doi.org/10.1007/s11010-024-04985-3openalex-snapshot
A crazy trio in Parkinson's disease: metabolism alteration, α-synuclein aggregation, and oxidative stress
inferred← citeshttps://doi.org/10.1007/s11033-024-09520-7openalex-snapshot
Interplay between α-synuclein and parkin genes: Insights of Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s11515-012-1216-0openalex-snapshot
Application of reprogrammed patient cells to investigate the etiology of neurological and psychiatric disorders
inferred← citeshttps://doi.org/10.1007/s11910-012-0288-1openalex-snapshot
Redefining Parkinson’s Disease Research Using Induced Pluripotent Stem Cells
inferred← citeshttps://doi.org/10.1007/s11910-018-0893-8openalex-snapshot
Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson’s Disease-Relevant Phenotypes
inferred← citeshttps://doi.org/10.1007/s12017-017-8454-xopenalex-snapshot
Mimicking Parkinson’s Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models
inferred← citeshttps://doi.org/10.1007/s12035-016-0214-7openalex-snapshot
Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy
inferred← citeshttps://doi.org/10.1007/s12035-016-9714-8openalex-snapshot
Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases?
inferred← citeshttps://doi.org/10.1007/s12035-018-1232-4openalex-snapshot
Misfolded Protein Linked Strategies Toward Biomarker Development for Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/s12035-020-01926-1openalex-snapshot
The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/s12035-023-03293-zopenalex-snapshot
Overexpression of Parkin in the Neuronal Progenitor Cells from a Patient with Parkinson’s Disease Shifts the Transcriptome Towards the Normal State
inferred← citeshttps://doi.org/10.1007/s12035-023-03481-xopenalex-snapshot
Linking Heat Shock Protein 70 and Parkin in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/s12041-018-0960-6openalex-snapshot
Parkinson’s disease: what the model systems have taught us so far
inferred← citeshttps://doi.org/10.1007/s12640-022-00564-wopenalex-snapshot
CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics
inferred← citeshttps://doi.org/10.1007/s13311-015-0354-xopenalex-snapshot
The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment
inferred← citeshttps://doi.org/10.1007/s13721-020-00280-5openalex-snapshot
Identification of potential Parkinson’s disease biomarkers using computational biology approaches
inferred← citeshttps://doi.org/10.1007/s15202-015-0892-4openalex-snapshot
Humane Stammzellen: eine Perspektive für den Morbus Parkinson?
inferred← citeshttps://doi.org/10.1016/b978-0-12-405195-9.00009-3openalex-snapshot
Induced Pluripotent Stem Cells (iPSCs) to Study and Treat Movement Disorders
inferred← citeshttps://doi.org/10.1016/b978-0-12-812146-7.00007-xopenalex-snapshot
Loss of PINK1 or Parkin Function Results in a Progressive Loss of Mitochondrial Function
inferred← citeshttps://doi.org/10.1016/b978-0-12-822135-8.00008-2openalex-snapshot
Induced pluripotent stem cell derived from postmortem tissue in neurodegenerative disease research
inferred← citeshttps://doi.org/10.1016/b978-0-12-823882-0.00007-2openalex-snapshot
iPSC for modeling of metabolic and neurodegenerative disorders
inferred← citeshttps://doi.org/10.1016/b978-0-443-21992-4.00012-9openalex-snapshot
Dopamine neurotransmission in Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.arr.2020.101069openalex-snapshot
Discovery of new epigenomics-based biomarkers and the early diagnosis of neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.bbadis.2019.03.004openalex-snapshot
Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.bbi.2024.04.023openalex-snapshot
More than a number: Incorporating the aged phenotype to improve in vitro and in vivo modeling of neurodegenerative disease
inferred← citeshttps://doi.org/10.1016/j.bbrc.2016.12.188openalex-snapshot
Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons
inferred← citeshttps://doi.org/10.1016/j.bbrc.2019.06.089openalex-snapshot
Attenuation of PRRX2 and HEY2 enables efficient conversion of adult human skin fibroblasts to neurons
inferred← citeshttps://doi.org/10.1016/j.bbrc.2019.11.176openalex-snapshot
Multipotent stem cells with neural crest stem cells characteristics exist in bovine adipose tissue
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.113591openalex-snapshot
Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies
inferred← citeshttps://doi.org/10.1016/j.brainresbull.2020.02.001openalex-snapshot
Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson’s disease (PD) – A road to discovery?
inferred← citeshttps://doi.org/10.1016/j.ceb.2012.08.014openalex-snapshot
iPSC technology to study human aging and aging-related disorders
inferred← citeshttps://doi.org/10.1016/j.celrep.2014.10.023openalex-snapshot
iPSC-Derived Dopamine Neurons Reveal Differences between Monozygotic Twins Discordant for Parkinson’s Disease
inferred← citeshttps://doi.org/10.1016/j.celrep.2017.04.023openalex-snapshot
Dopamine Induces Oscillatory Activities in Human Midbrain Neurons with Parkin Mutations
inferred← citeshttps://doi.org/10.1016/j.cmet.2013.06.005openalex-snapshot
Mitochondrial Regulation in Pluripotent Stem Cells
inferred← citeshttps://doi.org/10.1016/j.ejphar.2024.176819openalex-snapshot
Experimental models of Parkinson's disease: Challenges and Opportunities
inferred← citeshttps://doi.org/10.1016/j.expneurol.2012.12.017openalex-snapshot
Stem cells and the treatment of Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.expneurol.2013.01.001openalex-snapshot
Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity
inferred← citeshttps://doi.org/10.1016/j.gde.2012.07.004openalex-snapshot
Human disease modeling with induced pluripotent stem cells
inferred← citeshttps://doi.org/10.1016/j.jhazmat.2021.125230openalex-snapshot
Long-term exposure to 2-amino-3-methylimidazo[4,5-f]quinoline can trigger a potential risk of Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.molmed.2016.05.010openalex-snapshot
iPSCs: On the Road to Reprogramming Aging
inferred← citeshttps://doi.org/10.1016/j.nbd.2019.01.023openalex-snapshot
Insights into GBA Parkinson's disease pathology and therapy with induced pluripotent stem cell model systems
inferred← citeshttps://doi.org/10.1016/j.nbd.2019.104545openalex-snapshot
The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.nbd.2019.104581openalex-snapshot
Perturbations in RhoA signalling cause altered migration and impaired neuritogenesis in human iPSC-derived neural cells with PARK2 mutation
inferred← citeshttps://doi.org/10.1016/j.nbt.2014.05.001openalex-snapshot
Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.neuint.2022.105344openalex-snapshot
Oxidative phosphorylation mediated pathogenesis of Parkinson's disease and its implication via Akt signaling
inferred← citeshttps://doi.org/10.1016/j.neulet.2019.04.029openalex-snapshot
Therapeutic approaches to enhance PINK1/Parkin mediated mitophagy for the treatment of Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.neuron.2013.06.002openalex-snapshot
Remodeling Neurodegeneration: Somatic Cell Reprogramming-Based Models of Adult Neurological Disorders
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2013.08.035openalex-snapshot
Parkinson's disease in a dish – Using stem cells as a molecular tool
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2013.12.007openalex-snapshot
Antioxidant gene therapy against neuronal cell death
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2014.06.006openalex-snapshot
Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders
inferred← citeshttps://doi.org/10.1016/j.pneurobio.2016.01.006openalex-snapshot
The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders
inferred← citeshttps://doi.org/10.1016/j.pneurobio.2018.04.005openalex-snapshot
Pluripotent stem cell-based therapy for Parkinson’s disease: Current status and future prospects
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2019.109674openalex-snapshot
Recent advances of induced pluripotent stem cells application in neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.redox.2017.01.009openalex-snapshot
Induced dopaminergic neurons: A new promise for Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.redox.2018.10.003openalex-snapshot
Monoamine oxidase-A promotes protective autophagy in human SH-SY5Y neuroblastoma cells through Bcl-2 phosphorylation
inferred← citeshttps://doi.org/10.1016/j.reth.2020.11.006openalex-snapshot
iPSC for modeling neurodegenerative disorders
inferred← citeshttps://doi.org/10.1016/j.scitotenv.2023.168307openalex-snapshot
Elevated parkinsonism pathological markers in dopaminergic neurons with developmental exposure to atrazine
inferred← citeshttps://doi.org/10.1016/j.scr.2013.06.005openalex-snapshot
Alginate microcapsule as a 3D platform for the efficient differentiation of human embryonic stem cells to dopamine neurons
inferred← citeshttps://doi.org/10.1016/j.stem.2013.05.018openalex-snapshot
Therapeutic Translation of iPSCs for Treating Neurological Disease
inferred← citeshttps://doi.org/10.1016/j.stem.2014.02.004openalex-snapshot
Modeling ALS with iPSCs Reveals that Mutant SOD1 Misregulates Neurofilament Balance in Motor Neurons
inferred← citeshttps://doi.org/10.1016/j.stemcr.2015.02.019openalex-snapshot
Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines
inferred← citeshttps://doi.org/10.1016/j.stemcr.2016.07.017openalex-snapshot
Expandable and Rapidly Differentiating Human Induced Neural Stem Cell Lines for Multiple Tissue Engineering Applications
inferred← citeshttps://doi.org/10.1016/j.stemcr.2016.08.012openalex-snapshot
Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation
inferred← citeshttps://doi.org/10.1016/j.stemcr.2019.12.005openalex-snapshot
Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons
inferred← citeshttps://doi.org/10.1016/j.tins.2018.11.001openalex-snapshot
Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1016/j.tins.2022.05.001openalex-snapshot
Induced pluripotent stem cells: a tool for modeling Parkinson’s disease
inferred← citeshttps://doi.org/10.1021/ac303806jopenalex-snapshot
Nucleolar Molecular Signature of Pluripotent Stem Cells
inferred← citeshttps://doi.org/10.1021/ac4006183openalex-snapshot
Parallel On-Chip Analysis of Single Vesicle Neurotransmitter Release
inferred← citeshttps://doi.org/10.1038/cddis.2014.333openalex-snapshot
Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson’s disease
inferred← citeshttps://doi.org/10.1038/mp.2015.101openalex-snapshot
Direct conversion of human fibroblasts to induced serotonergic neurons
inferred← citeshttps://doi.org/10.1038/ncomms10100openalex-snapshot
Cell cycle and p53 gate the direct conversion of human fibroblasts to dopaminergic neurons
inferred← citeshttps://doi.org/10.1038/nrd.2016.245openalex-snapshot
Induced pluripotent stem cell technology: a decade of progress
inferred← citeshttps://doi.org/10.1038/nrg3764openalex-snapshot
Investigating human disease using stem cell models
inferred← citeshttps://doi.org/10.1038/s41380-022-01628-1openalex-snapshot
Generation of human A9 dopaminergic pacemakers from induced pluripotent stem cells
inferred← citeshttps://doi.org/10.1038/s41380-025-03225-4openalex-snapshot
Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons
inferred← citeshttps://doi.org/10.1038/s41398-021-01387-7openalex-snapshot
Parkin regulates drug-taking behavior in rat model of methamphetamine use disorder
inferred← citeshttps://doi.org/10.1038/s41419-018-0891-4openalex-snapshot
Transdifferentiation: a new promise for neurodegenerative diseases
inferred← citeshttps://doi.org/10.1038/s41531-020-0110-8openalex-snapshot
Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells
inferred← citeshttps://doi.org/10.1038/s41531-021-00161-2openalex-snapshot
Dynamic control of the dopamine transporter in neurotransmission and homeostasis
inferred← citeshttps://doi.org/10.1038/s41531-025-01137-2openalex-snapshot
Investigating the ageing-Parkinson’s disease nexus: standardisation of in vitro models and techniques by the PD-AGE network
inferred← citeshttps://doi.org/10.1038/s41531-026-01371-2openalex-snapshot
High molecular weight insoluble parkin in the substantia nigra of patients with idiopathic Parkinson’s disease
inferred← citeshttps://doi.org/10.1038/s41560-025-01919-1openalex-snapshot
Centimetre-scale fullerene-free tin-based perovskite solar cells with a 14.51% certified efficiency
inferred← citeshttps://doi.org/10.1038/s41598-018-19291-4openalex-snapshot
Using intracellular markers to identify a novel set of surface markers for live cell purification from a heterogeneous hIPSC culture
inferred← citeshttps://doi.org/10.1038/s41598-018-27653-1openalex-snapshot
Sequential Application of Discrete Topographical Patterns Enhances Derivation of Functional Mesencephalic Dopaminergic Neurons from Human Induced Pluripotent Stem Cells
inferred← citeshttps://doi.org/10.1038/s41598-020-67143-xopenalex-snapshot
TET1 Deficiency Impairs Morphogen-free Differentiation of Human Embryonic Stem Cells to Neuroectoderm
inferred← citeshttps://doi.org/10.1038/s41598-022-22158-4openalex-snapshot
Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons
inferred← citeshttps://doi.org/10.1042/bcj20170476openalex-snapshot
Activation mechanisms of the E3 ubiquitin ligase parkin
inferred← citeshttps://doi.org/10.1042/bst20120159openalex-snapshot
Cellular reprogramming: a new approach to modelling Parkinson's disease
inferred← citeshttps://doi.org/10.1042/bst20130194openalex-snapshot
Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease
inferred← citeshttps://doi.org/10.1073/pnas.1617259114openalex-snapshot
Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson’s disease
inferred← citeshttps://doi.org/10.1074/jbc.ra117.000499openalex-snapshot
Comparative analysis of Parkinson's disease–associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons
inferred← citeshttps://doi.org/10.1080/15548627.2026.2669458openalex-snapshot
PRKN/parkin-mediated control of SNCA (synuclein alpha) and chaperone-mediated autophagy are defective in cellular, mice models and Parkinson disease-affected brains
inferred← citeshttps://doi.org/10.1080/17460441.2020.1703671openalex-snapshot
Organoid and pluripotent stem cells in Parkinson’s disease modeling: an expert view on their value to drug discovery
inferred← citeshttps://doi.org/10.1089/scd.2013.0576openalex-snapshot
Human Stem Cells for Craniomaxillofacial Reconstruction
inferred← citeshttps://doi.org/10.1089/scd.2015.0079openalex-snapshot
Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling
inferred← citeshttps://doi.org/10.1093/brain/awad064openalex-snapshot
Impaired dopamine release in Parkinson’s disease
inferred← citeshttps://doi.org/10.1093/brain/awx172openalex-snapshot
Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders
inferred← citeshttps://doi.org/10.1093/hmg/ddw209openalex-snapshot
Disease modelling using human iPSCs
inferred← citeshttps://doi.org/10.1093/schbul/sbt103openalex-snapshot
Will Brain Cells Derived From Induced Pluripotent Stem Cells or Directly Converted From Somatic Cells (iNs) Be Useful for Schizophrenia Research?
inferred← citeshttps://doi.org/10.1096/fj.201600932ropenalex-snapshot
Human polymorphisms in nicotinic receptors: a functional analysis in iPS‐derived dopaminergic neurons
inferred← citeshttps://doi.org/10.1097/ypg.0000000000000211openalex-snapshot
Cross-species models of attention-deficit/hyperactivity disorder and autism spectrum disorder
inferred← citeshttps://doi.org/10.1098/rsob.180177openalex-snapshot
Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease
inferred← citeshttps://doi.org/10.1101/cshperspect.a035659openalex-snapshot
Modeling Brain Disorders Using Induced Pluripotent Stem Cells
inferred← citeshttps://doi.org/10.1111/cpr.12229openalex-snapshot
Induced pluripotent stem cells and Parkinson's disease: modelling and treatment
inferred← citeshttps://doi.org/10.1111/ejn.14264openalex-snapshot
Mitochondrial dysfunction and oxidative stress in induced pluripotent stem cell models of Parkinson's disease
inferred← citeshttps://doi.org/10.1111/ejn.14345openalex-snapshot
Induced pluripotent stem cell‐based modeling of mutant LRRK 2‐associated Parkinson's disease
inferred← citeshttps://doi.org/10.1111/jcmm.13512openalex-snapshot
SPION ‐mediated miR‐141 promotes the differentiation of Hu AESC s into dopaminergic neuron‐like cells via suppressing lnc RNA ‐ HOTAIR
inferred← citeshttps://doi.org/10.1111/jnc.12625openalex-snapshot
Modeling human neurological disorders with induced pluripotent stem cells
inferred← citeshttps://doi.org/10.1124/pharmrev.120.000189openalex-snapshot
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
inferred← citeshttps://doi.org/10.1126/sciadv.aaz0298openalex-snapshot
Transient inhibition of mTOR in human pluripotent stem cells enables robust formation of mouse-human chimeric embryos
inferred← citeshttps://doi.org/10.1134/s0026893313040183openalex-snapshot
Recovery from Parkinsonism with N-acetylcysteine-differentiated neurons
inferred← citeshttps://doi.org/10.1139/cjpp-2015-0459openalex-snapshot
Toxicity testing and drug screening using iPSC-derived hepatocytes, cardiomyocytes, and neural cells
inferred← citeshttps://doi.org/10.1152/physrev.00039.2017openalex-snapshot
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
inferred← citeshttps://doi.org/10.1152/physrev.00041.2021openalex-snapshot
Mitochondrial quality control in health and in Parkinson’s disease
inferred← citeshttps://doi.org/10.1155/2012/346053openalex-snapshot
Induced Pluripotent Stem Cells to Model and Treat Neurogenetic Disorders
inferred← citeshttps://doi.org/10.1155/2012/926147openalex-snapshot
Parkinson’s Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson’s Disease, If Anything?
inferred← citeshttps://doi.org/10.1155/2015/103969openalex-snapshot
Recent Advances in Methamphetamine Neurotoxicity Mechanisms and Its Molecular Pathophysiology
inferred← citeshttps://doi.org/10.1155/2016/4126214openalex-snapshot
The Progress of Induced Pluripotent Stem Cells as Models of Parkinson’s Disease
inferred← citeshttps://doi.org/10.1155/2016/5838934openalex-snapshot
Generation of Cholinergic and Dopaminergic Interneurons from Human Pluripotent Stem Cells as a Relevant Tool for In Vitro Modeling of Neurological Disorders Pathology and Therapy
inferred← citeshttps://doi.org/10.1155/2016/9464591openalex-snapshot
Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC‐Based Models
inferred← citeshttps://doi.org/10.1155/2020/1061470openalex-snapshot
Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells
inferred← citeshttps://doi.org/10.1177/1535370214538588openalex-snapshot
Solving the puzzle of Parkinson’s disease using induced pluripotent stem cells
inferred← citeshttps://doi.org/10.1177/1535370215584932openalex-snapshot
Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification
inferred← citeshttps://doi.org/10.1177/1535370220961788openalex-snapshot
Modeling the pathophysiology of Parkinson’s disease in patient-specific neurons
inferred← citeshttps://doi.org/10.1177/1535370220963755openalex-snapshot
Direct conversion of adult human retinal pigmented epithelium cells to neurons with photoreceptor properties
inferred← citeshttps://doi.org/10.1186/1756-6606-5-35openalex-snapshot
Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
inferred← citeshttps://doi.org/10.1186/s13041-019-0426-7openalex-snapshot
Reduced expression of somatostatin in GABAergic interneurons derived from induced pluripotent stem cells of patients with parkin mutations
inferred← citeshttps://doi.org/10.1186/s13041-021-00771-0openalex-snapshot
Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons
inferred← citeshttps://doi.org/10.1186/s13195-015-0129-yopenalex-snapshot
Connectivity and circuitry in a dish versus in a brain
inferred← citeshttps://doi.org/10.1186/s40035-020-00229-8openalex-snapshot
Multitasking guardian of mitochondrial quality: Parkin function and Parkinson’s disease
inferred← citeshttps://doi.org/10.1186/s40035-022-00308-yopenalex-snapshot
The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders
inferred← citeshttps://doi.org/10.1186/s40478-019-0863-7openalex-snapshot
Cellular alterations identified in pluripotent stem cell-derived midbrain spheroids generated from a female patient with progressive external ophthalmoplegia and parkinsonism who carries a novel variation (p.Q811R) in the POLG1 gene
inferred← citeshttps://doi.org/10.1186/s40779-020-00284-2openalex-snapshot
Direct conversion of human fibroblasts into dopaminergic neuron-like cells using small molecules and protein factors
inferred← citeshttps://doi.org/10.1201/9781315402185-6openalex-snapshot
5 Stem Cells for Parkinson’s Disease
inferred← citeshttps://doi.org/10.1242/dmm.026294openalex-snapshot
Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
inferred← citeshttps://doi.org/10.1248/bpb.b12-00929openalex-snapshot
Therapeutic Application of Stem Cell Technology toward the Treatment of Parkinson’s Disease
inferred← citeshttps://doi.org/10.12688/mniopenres.12816.1openalex-snapshot
Generation of human midbrain organoids from induced pluripotent stem cells
inferred← citeshttps://doi.org/10.12688/mniopenres.12816.2openalex-snapshot
Generation of human midbrain organoids from induced pluripotent stem cells
inferred← citeshttps://doi.org/10.1371/journal.pgen.1002794openalex-snapshot
Gene Expression Profiles in Parkinson Disease Prefrontal Cortex Implicate FOXO1 and Genes under Its Transcriptional Regulation
inferred← citeshttps://doi.org/10.1371/journal.pone.0041572openalex-snapshot
Establishment of Induced Pluripotent Stem Cells from Centenarians for Neurodegenerative Disease Research
inferred← citeshttps://doi.org/10.1371/journal.pone.0048498openalex-snapshot
Oscillatory Threshold Logic
inferred← citeshttps://doi.org/10.1371/journal.pone.0083914openalex-snapshot
Ubiquitination Increases Parkin Activity to Promote Autophagic α-Synuclein Clearance
inferred← citeshttps://doi.org/10.1371/journal.pone.0084894openalex-snapshot
Behavioral and Neurotransmitter Abnormalities in Mice Deficient for Parkin, DJ-1 and Superoxide Dismutase
inferred← citeshttps://doi.org/10.1371/journal.pone.0087388openalex-snapshot
Physiological Characterisation of Human iPS-Derived Dopaminergic Neurons
inferred← citeshttps://doi.org/10.1371/journal.pone.0154890openalex-snapshot
Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson’s Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations
inferred← citeshttps://doi.org/10.1515/hsz-2019-0142openalex-snapshot
Neuronal microtubules and proteins linked to Parkinson’s disease: a relevant interaction?
inferred← citeshttps://doi.org/10.15200/winn.148233.37308openalex-snapshot
Stem cells in Parkinson’s disease: an update
inferred← citeshttps://doi.org/10.1523/jneurosci.0636-16.2016openalex-snapshot
A New Glucocerebrosidase Chaperone Reduces -Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism
inferred← citeshttps://doi.org/10.15252/emmm.201505439openalex-snapshot
Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients
inferred← citeshttps://doi.org/10.15283/ijsc23169openalex-snapshot
Stem Cell-Based Approaches in Parkinson's Disease Research
inferred← citeshttps://doi.org/10.18192/uojm.v9i1.4163openalex-snapshot
From Zero to Neuro-Reprogramming: Innovations in Translational Neuroregenerative Medicine
inferred← citeshttps://doi.org/10.21037/atm.2019.11.16openalex-snapshot
A compendious summary of Parkinson’s disease patient-derived iPSCs in the first decade
inferred← citeshttps://doi.org/10.21037/sci.2017.06.08openalex-snapshot
Cell replacement therapy is the remedial solution for treating Parkinson’s disease
inferred← citeshttps://doi.org/10.21203/rs.3.rs-6298077/v1openalex-snapshot
N-acetyl-l-leucine lowers pS129-synuclein and improves synaptic function in models of Parkinson’s disease
inferred← citeshttps://doi.org/10.21307/ane-2019-026openalex-snapshot
The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson’s disease
inferred← citeshttps://doi.org/10.2174/187152731131200128openalex-snapshot
Induced Pluripotent Stem Cell-Based Studies of Parkinson's Disease: Challenges and Promises
inferred← citeshttps://doi.org/10.2217/nmt.12.25openalex-snapshot
The Role of Parkin in Parkinson’s Disease: A Stem Cell Perspective
inferred← citeshttps://doi.org/10.23868/201707012openalex-snapshot
Cellular models, genomic technologies and clinical practice: a synthesis of knowledge for the study of the mechanisms, diagnostics and treatment of Parkinson's disease
inferred← citeshttps://doi.org/10.25335/m5ph73openalex-snapshot
Parkin mediated mitochondrial quality control in central dopamine neurons
inferred← citeshttps://doi.org/10.2741/4321openalex-snapshot
Functions and characteristics of PINK1 and Parkin in cancer
showing the first 200 of 250 · page through all 250
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.